2.5.1. Potassium-Sparing Diuretics (Aldosterone antagonists)
For SPS Guidance on Eplerenone monitoring in Adults in Primary Care please click here
For SPS Guidance on Spironolactone monitoring in Adults in Primary Care please click here
Finerenone - option for treating stage 3 and 4 chronic kidney disease (with albuminuria) associated with type 2 diabetes in adults (only for this indication).
For NICE TA 877 Finerenone for treating chronic kidney disease in type 2 diabetes Click Here
For Cardiovascular system - guidance Click Here
| Pack |
|---|
| 100 tablet |
| 28 tablet |
| 30 tablet |
| 500 tablet |
| Pack |
|---|
| 100 tablet |
| 28 tablet |
| 30 tablet |
| Pack |
|---|
| 100 tablet |
| 20 tablet |
| 28 tablet |
| 30 tablet |
| 60 tablet |
First line option for patients 3-14 days post MI and with signs and symptoms of heart failure
| Pack |
|---|
| 28 tablet |
| 30 tablet |
| Pack |
|---|
| 28 tablet |
| 30 tablet |
Finerenone - Option for treating stage 3 and 4 chronic kidney disease (with albuminuria) associated with type 2 diabetes in adults as per NICE TA 877
| Pack |
|---|
| 28 tablet |
| Pack |
|---|
| 28 tablet |
- First Line Choice
- On Formulary
- Specialist Initiation Only
- Hospital Only
- KMPT Initiation Only